USPTO serial 97483940
VERSATILE
Reviewed by CopyMark Law Group
Status 807Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- AIKENS, RONALD E
- Law office
- TMO LAW OFFICE 112
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with VERSATILE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew T. Pettit
Andrew T. Pettit PERKINS COIE LLPP.O. BOX 2608SEATTLE, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Data processing services for medical, clinical, and scientific purposes; data processing services, namely, analysis of data related to primers to identify those primers that are able to induce a reaction of interest; data processing services, namely, analysis of data related to nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; data processing services for medical, clinical, and scientific purposes | ACTIVE | Jun 1, 2023 |
| 042 | Software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering combinations of primers for achieving a reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating biological, chemical, and biochemical reactions through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for discovering tiling solutions for achieving a reaction of interest, each tiling solution being representative of a different combination of primers, and then determining the optimal tiling solution for achieving the reaction of interest; software as a service (SaaS), namely, hosting non-downloadable software for use by others for determining chemistry through the use of artificial intelligence or machine learning; software as a service (SaaS), namely, hosting non-downloadable software for use by others for designing primer pools for reactions without the need for laboratory testing; software as a service (SaaS), namely, hosting non-downloadable software for use by others for simulating interactions involving nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, diagnostic research, and diagnostics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for bioinformatics; software as a service (SaaS), namely, hosting non-downloadable software for use by others for health and wellness assessment, namely, for use in genomic analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for genetic and bioinformatics analysis; software as a service (SaaS), namely, hosting non-downloadable software for use by others for testing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules for research purposes; bioinformatics services, namely, product research and development in the field of bioinformatics; developing artificial intelligence algorithms and machine learning algorithms for medical, clinical, and scientific purposes; developing artificial intelligence algorithms and machine learning algorithms for use by others to develop products related to the diagnosis, management, or treatment of disease; consulting relating to research and development of products related to the diagnosis, management, or treatment of disease; providing a service for designing primers on behalf of others; providing a service for designing primers on behalf of healthcare entities, including hospital systems, pharmaceutical companies, and researchers | ACTIVE | Jun 1, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pillar Biosciences, Inc.
- Other trademarks owned by Pillar Biosciences, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named VERSATILE
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 12, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jun 12, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 12, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 12, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 11, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 10, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 16, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 16, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 15, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 15, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 3, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 3, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 3, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 12, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 14, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 12, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 12, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 12, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 10, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 10, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 10, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 6, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2022 | NWAP | NEW APPLICATION ENTERED | — |